Characteristics of patients and investigations
| n | |
|---|---|
| LUL, left upper lower; LLL, left lower lobe; RUL, right upper lobe; RLL, right lower lobe; RML, right middle lobe; EUS-FNA, endoscopic ultrasound with real-time guided fine needle aspiration; EBUS-TBNA, endobronchial endoscopic ultrasound with real-time guided transbronchial needle aspiration. | |
| Number of patients | 52 |
| Lymph nodes with pathology | 105 |
| Sex | |
| Male | 39 (75%) |
| Female | 13 (25%) |
| Median (range) age (years) | 68 (48–80) |
| Site of lung tumour | |
| LUL | 9 (17%) |
| LLL | 12 (23%) |
| RUL | 17 (33%) |
| RLL | 12 (23%) |
| RML | 2 (4%) |
| Primary tumour pathology obtained | 35 (67%) |
| With bronchoscopy | 17 (49%) |
| With transthoracic puncture (CT guided) | 5 (14%) |
| With a surgical procedure | 13 (37%) |
| Site of thoracic lymph nodes | |
| Upper mediastinum (2–3–4–5–6) | 50 (48%) |
| Subcarinal region (7) | 32 (31%) |
| Lower mediastinum (8–9) | 12 (11%) |
| Hilar lymph nodes (10–11) | 11 (10%) |
| Lymph node pathology obtained | 50 (96%) |
| With mediastinoscopy/surgery | 21 (42%) |
| With EUS-FNA or EBUS-TBNA | 24 (48%) |
| With EUS-FNA or EBUS-TBNA followed by surgical staging | 5 (10%) |